Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Locally Advanced Unresectable or Metastatic Solid Tumors × folfirinox × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Pancreatic Neoplasms 9 Colorectal Neoplasms 3 Resectable Pancreatic Cancer 1 Pancreatic Cancer Metastatic 1 Neoplasms, Basal Cell 1 Locally Advanced Unresectable or Metastatic Solid Tumors 1 Localized Pancreatic Adenocarcinoma 1 Gastroesophageal Adenocarcinoma 1 Colorectal Cancer Metastatic 1

Interventions

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05458219 2025-11-10

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1 Recruiting

Other solid neoplasm

Locally Advanced Unresectable or Metastatic Solid Tumors

Data powered by HemOnc (CC BY 4.0) Colophon ⚡